Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2001
10/11/2001CA2404896A1 Human ion channel protein and polynucleotides encoding the same
10/11/2001CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001CA2404541A1 G-protein coupled receptors and nucleic acids encoding same
10/11/2001CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001CA2404365A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
10/11/2001CA2404350A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001CA2404291A1 Butylnitrone containing compositons for inhibition of cancer development
10/11/2001CA2404040A1 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists
10/11/2001CA2403998A1 Mucin-1 specific binding members and methods of use thereof
10/11/2001CA2403979A1 Cold-adapted equine influenza viruses
10/11/2001CA2403964A1 Compositions and methods for dendritic cell-based immunotherapy
10/11/2001CA2401948A1 Cd20/ige-receptor like molecules and uses thereof
10/10/2001EP1142910A1 Inhibitors for the formation of soluble human CD23
10/10/2001EP1142906A1 A hepatitis B virus (subtype ayw) surface antigen variant
10/10/2001EP1142473A1 Method of acquiring immunological tolerance
10/10/2001EP1141723A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists
10/10/2001EP1141721A1 Conjugates for detecting viruses that cause diseases of the respiratory tract and use thereof
10/10/2001EP1141720A1 Detection of preactivated phagocytes
10/10/2001EP1141487A1 System for predicting compaction performance
10/10/2001EP1141389A2 Reagents and methods useful for detecting diseases of the breast
10/10/2001EP1141365A1 Method for preparing suspension of stable posiplexes
10/10/2001EP1141353A2 Plant cell cycle genes and uses thereof
10/10/2001EP1141326A2 Human akt-3
10/10/2001EP1141316A1 Hepatitis y virus
10/10/2001EP1141315A2 Modified hiv env polypeptides
10/10/2001EP1141314A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/10/2001EP1141313A2 Improved expression of hiv polypeptides and production of virus-like particles
10/10/2001EP1141312A2 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
10/10/2001EP1141311A1 Protective antigen of group a streptococci (spa)
10/10/2001EP1141309A1 Streptococcal abc transporter protein
10/10/2001EP1141308A2 Group b streptococcus proteins, and their use
10/10/2001EP1141306A2 Streptococcus antigens
10/10/2001EP1141305A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum
10/10/2001EP1141290A2 Compositions and methods for therapy and diagnosis of ovarian cancer
10/10/2001EP1141289A2 Compositions and method for the treatement of tumors
10/10/2001EP1141286A1 Cytokine receptor chain
10/10/2001EP1141280A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors
10/10/2001EP1141276A2 Novel polypeptides and nucleic acids encoding same
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141268A2 $i(A. FUMIGATUS) ACETYL COENZYME-A CARBOXYLASE GENES AND POLYPEPTIDES AND USES THEREOF
10/10/2001EP1141247A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
10/10/2001EP1141246A2 Non-myeloablative tolerogenic treatment
10/10/2001EP1141245A1 Somatic cells with ablated prp gene and methods of use
10/10/2001EP1141243A2 Methods of immunosuppression
10/10/2001EP1141240A1 Use of cd40 engagement to alter t cell receptor usage
10/10/2001EP1141079A1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
10/10/2001EP1141028A2 Human monoclonal antibodies to ctla-4
10/10/2001EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
10/10/2001EP1141026A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
10/10/2001EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor
10/10/2001EP1141018A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
10/10/2001EP1141017A2 Characterization of the soc/crac calcium channel protein family
10/10/2001EP1141009A2 Reagents and methods useful for detecting diseases of the breast
10/10/2001EP1141007A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
10/10/2001EP1141000A1 Superantigens
10/10/2001EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140997A2 Chlamydia trachomatis antigens
10/10/2001EP1140996A2 Type iii secretion system antigens from bordetella pertussis
10/10/2001EP1140994A1 Outer surface proteins, their genes, and their use
10/10/2001EP1140987A1 Peptides for inhibiting hpv e6 proteins
10/10/2001EP1140978A1 Methods of identifying antigen gene sequences
10/10/2001EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140967A1 Targeted gene transfer using g protein coupled receptors
10/10/2001EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140290A2 Synergistic tumorcidal response induced by histamine
10/10/2001EP1140214A1 Removal of biological contaminants
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140175A2 Antibodies to truncated vegf-d and uses thereof
10/10/2001EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
10/10/2001EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof
10/10/2001EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation
10/10/2001EP1140170A1 Novel agents and methods for treatment and diagnosis of ocular disorders
10/10/2001EP1140169A2 Methods and compositions for decreasing allergic reactions to surface allergens
10/10/2001EP1140168A1 Use of antibodies for anticancer vaccination
10/10/2001EP1140167A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13
10/10/2001EP1140166A2 Novel adjuvant for subunit or component vaccines
10/10/2001EP1140165A1 Improved saponin adjuvant compositions and methods relating thereto
10/10/2001EP1140164A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/10/2001EP1140163A2 Combination of hepatitis b vaccine with antiviral agents
10/10/2001EP1140162A2 Vaccination method for efficient induction of cytotoxic t lymphocyte response
10/10/2001EP1140161A1 Synthetic virus-like particles with heterologous epitopes
10/10/2001EP1140160A2 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans
10/10/2001EP1140159A1 Oral vaccine against diarrhea
10/10/2001EP1140158A2 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/10/2001EP1140157A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
10/10/2001EP1140156A2 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
10/10/2001EP1140155A1 Improved recombinant hepatitis b surface antigen
10/10/2001EP1140154A2 Chorionic gonadotropin dna vaccines and methods
10/10/2001EP1140153A2 Improvement of tolerance to a xenograft
10/10/2001EP1140152A1 Method to produce inactivated w/o emulsion adjuvated vaccines
10/10/2001EP1140151A2 Compositions and methods for reducing or preventing fertilization in fish and birds
1 ... 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 ... 1823